Items
Details
Table of Contents
1. An uneasy balance : science advising and the politicization of science
2. Big science : the Human Genome Project and the public funding of science. Funding biomedical research : peer review versus pork barrel ; Choosing research directions : advocacy, the "disease
of-the-month," and Congressional oversight
3. Who owns the genome? The patenting of human genes. Who owns life? Mr. Moore's spleen ; The Canavan disease patent case
4. Manufacturing children : assisted reproductive technologies and self-regulation by scientists and clinicians. Brave new world revisited : human cloning and stem cells ; The Asilomar Conference on Recombinant DNA : a model for self-regulation?
5. Protecting the public : the FDA and new AIDS drugs. Seminal events : the evolution of regulations for research ; Placebo controls in clinical research
6. Cosmetic science : breast implants and the courts. Setting limits on expert testimony : Bendectin and birth defects ; DNA forensics in criminal trials : how new science becomes admissible
7. Selling science : new cancer treatments and the media. Responsible journalism : are there health risks from electromagnetic fields?
8. Concealing evidence : science, big business, and the tobacco industry. The academic-industrial complex and conflict of interest ; The darker side of science : scientific misconduct
9. Science in the national interest : bioterrorism and civil liberties. Emerging diseases : SARS and government responses ; Limiting research in an age of bioterrorism
10. Science misunderstood : genetically modified organisms and international trade. mad cow disease, international trade and the loss of public trust
11. Dangers in the environment : air pollution policy. Environmental poisoning : mitigating lead exposure ; Can we ever be safe? Risk and risk assessment
12. Who lives and who dies? Organ transplantation. Animals as organ factories : xenotransplantation ; Is there a right to die?
13. Concluding remarks : the challenges of science policy.
2. Big science : the Human Genome Project and the public funding of science. Funding biomedical research : peer review versus pork barrel ; Choosing research directions : advocacy, the "disease
of-the-month," and Congressional oversight
3. Who owns the genome? The patenting of human genes. Who owns life? Mr. Moore's spleen ; The Canavan disease patent case
4. Manufacturing children : assisted reproductive technologies and self-regulation by scientists and clinicians. Brave new world revisited : human cloning and stem cells ; The Asilomar Conference on Recombinant DNA : a model for self-regulation?
5. Protecting the public : the FDA and new AIDS drugs. Seminal events : the evolution of regulations for research ; Placebo controls in clinical research
6. Cosmetic science : breast implants and the courts. Setting limits on expert testimony : Bendectin and birth defects ; DNA forensics in criminal trials : how new science becomes admissible
7. Selling science : new cancer treatments and the media. Responsible journalism : are there health risks from electromagnetic fields?
8. Concealing evidence : science, big business, and the tobacco industry. The academic-industrial complex and conflict of interest ; The darker side of science : scientific misconduct
9. Science in the national interest : bioterrorism and civil liberties. Emerging diseases : SARS and government responses ; Limiting research in an age of bioterrorism
10. Science misunderstood : genetically modified organisms and international trade. mad cow disease, international trade and the loss of public trust
11. Dangers in the environment : air pollution policy. Environmental poisoning : mitigating lead exposure ; Can we ever be safe? Risk and risk assessment
12. Who lives and who dies? Organ transplantation. Animals as organ factories : xenotransplantation ; Is there a right to die?
13. Concluding remarks : the challenges of science policy.